Pharmacoeconomic analysis of infertility treatment in women with a suboptimal ovarian response
- Authors: Yagudina R.I.1, Kulikov A.Y.1, Krylov V.A.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- Issue: No 6 (2018)
- Pages: 77-84
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248199
- DOI: https://doi.org/10.18565/aig.2018.6.77-84
- ID: 248199
Cite item
Abstract
Full Text
About the authors
Roza I. Yagudina
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: yagudina@inbox.ru
Doctor of Philosophy, Professor, Head of the Department of Organization of Drug Provision and Pharmacoeconomics
Andrey Y. Kulikov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: 7677041@mail.ru
Doctor of Economics, Professor of the Department of Organization of Drug Supply and Pharmacoeconomics
Vyacheslav A. Krylov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Email: krylov@mail.ru
post-graduate student of the Department of Organization of Drug Supply and Pharmacoeconomics
References
- Zegers-Hochschild F., Adamson G.D., de Mouzon J., Ishihara O., Mansour R., Nygren K. et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary on ART terminology, 2009. Fertil. Steril. 2009; 92(5): 1520-4.
- Серов В.Н., Кира Е.Ф., ред. Гинекология. Руководство для врачей. М.: Литтерра; 2008: 778-80.
- Сидорова И.С., Овсянникова Т.В., Макаров И.О., ред. Амбулаторно-поликлиническая помощь. Практическое руководство для врачей. М.: МЕДпресс-информ; 2009: 591-603.
- Здравоохранение в России. 2001: Стат. сб./ Росстат. М.; 2001.
- Здравоохранение в России. 2013: Стат. сб./ Росстат. М.; 2013.
- Здравоохранение в России. 2017: Стат. сб./ Росстат. М.; 2017.
- Указ Президента РФ от 9 октября 2007 г. N. 1351 „Об утверждении Концепции демографической политики Российской Федерации на период до 2025 года” (с изменениями и дополнениями).
- Доклад Министра здравоохранения Российской Федерации Вероники Скворцовой в Государственной Думе в рамках «Правительственного часа».
- Корсак В.С., Смирнова А.А., Шурыгина О.В. РАРЧ Отчет регистра ВРТ за 2015 год. В. кн.: Материалы XXVII международной конференции РАРЧ «Репродуктивные технологии сегодня и завтра». г. Санкт-Петербург 6-9 сентября 2017 года. СПб.; 2017.
- Ferraretti A.P., La Marca A., Fauser B.C., Tarlatzis B.; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum. Reprod. 2011; 26(7): 1616-24.
- Alviggi C., Andersen C.Y., Buehler K., Conforti A., De Placido G., Esteves S.C., Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number). A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil. Steril. 2016; 105(6): 1452-3.
- Bühler K.F., Fischer R. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study. Gynecol. Endocrinol. 2012; 28(5): 345-50.
- Alviggi C., Clarizia R., Pettersson K., Mollo A., Humaidan P., Strina I. et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod. Biomed. Online. 2009; 18: 9-14.
- Lehert P., Kolibianakis E.M., Venetis C.A., Schertz J., Saunders H., Arriagada P. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod. Biol. Endocrinol. 2014, 12: 17.
- Ferraretti A.P., Gianaroli L., Magli M.C., DAngelo A., Farfalli V., Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil. Steril. 2004; 82(6): 1521-6.
- Carone D., Caropreso C., Vitti A., Chiappetta R. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I. anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols. J. Endocrinol. Invest. 2012; 35(11): 996-1002.
- Данные Федеральной службы государственной статистики. (по состоянию на 26.04.2018)
- Sun W., Stegmann B.J., Henne W., Catherino W.H., Segars J.H. A new approach to ovarian reserve testing. Fertil. Steril. 2008; 90(6): 2196-202.
- Petraglia F., Serour G.I., Chapron C. The changing prevalence of infertility. Int. J. Gynaecol. Obstet. 2013; 123(Suppl. 2): S4-8
- Хабриев Р.У., Куликов А.Ю., Аринина Е.Е. Методологические основы фармакоэкономического анализа. М.: Медицина; 2011. 128с.